abemaciclib,venetoclax,rituximab,pirtobrutinib
eli lilly,roche,abbvie
['bruin', 'verzenio', 'monarche,(-monarcher)', 'jaypirca', 'monarche', 'eli lilly', ' lilly', '$lly']
eli lilly to present verzenio and jaypirca data at 2023 asco annual meeting, showcasing new analyses from phase 3 monarche and phase 1/2 bruin trials. $lly #positive 
Real-time news analysis & sentiment scoring for the stocks in the S&P500
Powered by @streetbeat_com of @gptnewstracker
Disclosure: https://t.co/sjkSk4W05p